C-Rad AB (publ) (CRAD-B) - Total Liabilities

Latest as of December 2025: Skr153.60 Million SEK ≈ $16.53 Million USD

Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) has total liabilities worth Skr153.60 Million SEK (≈ $16.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

C-Rad AB (publ) - Total Liabilities Trend (2008–2025)

This chart illustrates how C-Rad AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See CRAD-B working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

C-Rad AB (publ) Competitors by Total Liabilities

The table below lists competitors of C-Rad AB (publ) ranked by their total liabilities.

Company Country Total Liabilities
Alkim Alkali Kimya AS
IS:ALKIM
Turkey TL1.41 Billion
Thac Mo Hydropower JSC
VN:TMP
Vietnam ₫556.00 Billion
Tonlin Department Store Co Ltd
TW:2910
Taiwan NT$3.48 Billion
American Outdoor Brands Inc
NASDAQ:AOUT
USA $59.30 Million
Donegal Group B Inc
NASDAQ:DGICB
USA $1.20 Billion
Hunter Group ASA
OL:HUNT
Norway Nkr349.00K
Lake Shore Bancorp Inc
NASDAQ:LSBK
USA $579.63 Million
Paxman AB
ST:PAX
Sweden Skr59.89 Million

Liability Composition Analysis (2008–2025)

This chart breaks down C-Rad AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CRAD-B company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.09 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how C-Rad AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for C-Rad AB (publ) (2008–2025)

The table below shows the annual total liabilities of C-Rad AB (publ) from 2008 to 2025.

Year Total Liabilities Change
2025-12-31 Skr153.60 Million
≈ $16.53 Million
-6.55%
2024-12-31 Skr164.37 Million
≈ $17.69 Million
+34.29%
2023-12-31 Skr122.40 Million
≈ $13.17 Million
+26.67%
2022-12-31 Skr96.63 Million
≈ $10.40 Million
+27.79%
2021-12-31 Skr75.62 Million
≈ $8.14 Million
+6.90%
2020-12-31 Skr70.73 Million
≈ $7.61 Million
-5.00%
2019-12-31 Skr74.46 Million
≈ $8.01 Million
+40.56%
2018-12-31 Skr52.97 Million
≈ $5.70 Million
+13.55%
2017-12-31 Skr46.65 Million
≈ $5.02 Million
+48.09%
2016-12-31 Skr31.50 Million
≈ $3.39 Million
-6.19%
2015-12-31 Skr33.58 Million
≈ $3.61 Million
+2.92%
2014-12-31 Skr32.63 Million
≈ $3.51 Million
+37.41%
2013-12-31 Skr23.74 Million
≈ $2.56 Million
+8.61%
2012-12-31 Skr21.86 Million
≈ $2.35 Million
+20.19%
2011-12-31 Skr18.19 Million
≈ $1.96 Million
-7.69%
2010-12-31 Skr19.70 Million
≈ $2.12 Million
+31.18%
2009-12-31 Skr15.02 Million
≈ $1.62 Million
+12.65%
2008-12-31 Skr13.33 Million
≈ $1.43 Million
--

About C-Rad AB (publ)

ST:CRAD-B Sweden Medical Devices
Market Cap
$127.56 Million
Skr1.19 Billion SEK
Market Cap Rank
#18352 Global
#315 in Sweden
Share Price
Skr36.90
Change (1 day)
-0.27%
52-Week Range
Skr24.90 - Skr37.00
All Time High
Skr66.70
About

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more